Literature DB >> 10329202

Familial hypertrophic cardiomyopathy associated with a novel missense mutation affecting the ATP-binding region of the cardiac beta-myosin heavy chain.

H Bundgaard1, O Havndrup, P S Andersen, L A Larsen, N J Brandt, J Vuust, K Kjeldsen, M Christiansen.   

Abstract

Mutations in the cardiac beta -myosin heavy chain gene (MYH7), and other genes encoding cardiac sarcomere proteins may cause familial hypertrophic cardiomyopathy (F-HCM), an autosomal dominant disease, characterized by myocardial hypertrophy. We analysed the MYH7 gene in three generations of a family with one borderline and four clinically verified cases of hypertrophic cardiomyopathy, and identified a mutation in exon 7 changing the 190 arginine residue into a threonine residue. The mutation is located in the ATP-binding region of the myosin head and alters the charge in the F-helix close to the phosphate-binding P-loop. The mutation may thus interfere with the coupling between ATP-hydrolysis and the transition into mechanical energy. In conclusion, the novel Arg190Thr mutation in exon 7 of the MYH7 gene is associated with the development of symptomatic myocardial hypertrophy in adults. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329202     DOI: 10.1006/jmcc.1998.0911

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

Review 1.  Motor Proteins and Spermatogenesis.

Authors:  Siwen Wu; Huitao Li; Lingling Wang; Nathan Mak; Xiaolong Wu; Renshan Ge; Fei Sun; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy.

Authors:  Morten K Jensen; Ole Havndrup; Michael Christiansen; Paal S Andersen; Anna Axelsson; Lars Køber; Henning Bundgaard
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-01       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.